Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2000
05/11/2000CA2348705A1 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
05/11/2000CA2348701A1 Genes and vectors for conferring herbicide resistance in plants
05/11/2000CA2348421A1 Protein
05/11/2000CA2348063A1 Method for preparing solid phase conjugate vaccines
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347119A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000CA2344972A1 Cancer immunotherapy and diagnosis using universal tumor associated antigens, including htert
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/10/2000EP0999280A2 Episomally replicating vector, its preparation and use
05/10/2000EP0999279A1 Gene transfer method with the use of serum-free medium
05/10/2000EP0999271A2 Retinoid receptor compositions and methods
05/10/2000EP0999269A1 CDNA sequence and genomic organization for a 59.4 kDa neuronal-specific 7 transmembrane protein (pNEU60)
05/10/2000EP0999268A1 New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
05/10/2000EP0999221A1 Antibodies to a mammalian Langerhans cell antigen and their uses
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998573A2 Fusion proteins with an immunoglobulin hinge region linker
05/10/2000EP0998572A2 Aggrecan degrading metallo proteases
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998568A1 Mutant having uracil phosphoribosyl transferase activity
05/10/2000EP0998558A1 Wa545 compositions
05/10/2000EP0998557A2 Modified immunogenic pneumolysin, compositions and their use as vaccines
05/10/2000EP0998555A1 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
05/10/2000EP0998553A1 Protein tyrosine kinase 2(pyk2),nucleic acids, and assay
05/10/2000EP0998496A1 Isolated dendritic cell membrane protein genes
05/10/2000EP0998490A2 Secreted proteins and polynucleotides encoding them
05/10/2000EP0998306A1 Liposomal compositions for the delivery of nucleic acid catalysts
05/10/2000EP0998305A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
05/10/2000EP0998299A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
05/10/2000EP0998298A2 Method of an increasing the antigen presenting ability of monocytes
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0998191A1 A molecular marker for the gene determining the fructose to glucose ratio in mature tomato fruit
05/10/2000CN1252840A Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof
05/10/2000CN1252838A Geranyl diphosphate synthase genes
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252687A Improved storage and maintenance of blood products
05/10/2000CN1252685A Sugar cane production
05/10/2000CN1252440A Avid kyowamycin regulation gene for improving disinsection mychel yield
05/10/2000CA2287775A1 Attenuated forms of bovine viral diarrhea virus
05/09/2000US6060640 Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060582 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
05/09/2000US6060313 Methods for clone-multiplication of paphiopedilums
05/09/2000US6060312 Method for in vitro culturing of potato clones resistant to blackspot bruising and the potatoes produced therefrom
05/09/2000US6060311 Identifying a compound that inhibits retinoic acid suppression of ventricular muscle cell hypertrophy
05/09/2000US6060309 Responder cell clones from prediabetic or new onset diabetic patients which are specific for gad peptides are also disclosed.
05/09/2000US6060308 RNA respiratory syncytial virus vaccines
05/09/2000US6060303 Use in screening assays and as pharmaceuticals.
05/09/2000US6060299 Enzyme exhibiting mannase activity, cleaning compositions, and methods of use
05/09/2000US6060296 Protein kinases
05/09/2000US6060285 Process for the production of hetero-bispecific antibodies
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals
05/09/2000US6060275 Sprouty protein and coding sequence
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060272 Human G-protein coupled receptors
05/09/2000US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders
05/09/2000US6060264 Multiple drug resistance gene atrc of Aspergillus nidulans
05/09/2000US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
05/09/2000US6060250 Human transferases
05/09/2000US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/09/2000US6060064 Chimeric virus-like particle antigen presentation and delivery system
05/09/2000US6060053 Injectable chondrocyte-carrier suspension for treatment of vesicoureteral reflux and incontinence
05/09/2000US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells
05/09/2000US6060049 Surrogate tolerogenesis for the development of tolerance to xenografts
05/09/2000US6060048 Method for transplanting cells into the brain and therapeutic uses therefor
05/09/2000CA2182371C Method for separating rare cells from a population of cells
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/04/2000WO2000024937A2 Parallel methods for genomic analysis
05/04/2000WO2000024917A1 Targeted gene modification by parvoviral vectors
05/04/2000WO2000024916A1 Improved aav vector production
05/04/2000WO2000024914A2 Apomixis conferred by expression of serk interacting proteins
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024910A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography
05/04/2000WO2000024904A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024900A1 Maize kin17 orthologues and uses thereof
05/04/2000WO2000024899A2 Interleukin-1 homolog zil1a4
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000WO2000024893A2 Methods and compositions for the prevention and treatment of anemia
05/04/2000WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/04/2000WO2000024889A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
05/04/2000WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60)
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease
05/04/2000WO2000024878A2 Mutant luciferase having increased thermostability
05/04/2000WO2000024866A2 Multipotential human medullary stromal cell line of and uses thereof
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024776A1 Novel toll-like receptor and gene thereof
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024755A1 Ovary-specific genes and proteins
1 ... 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 ... 1827